Earlier, the South China Morning Post reported that Moderna CEO Stephane Bancel said it plans to initially recruit regarding 1,000 people in Hong Kong, using Hong Kong as a gateway to mainland China, and the Hong Kong office will support the delivery of mRNA vaccines and treatments in Hong Kong and Macau. medicines, and lead collaborations to develop new vaccines needed in Asia.
Moderna is also in discussions with the Hong Kong government to get its mRNA vaccine approved and available this year and in 2023, although the Hong Kong government has yet to make a decision, Bancel said. Moderna’s Omicron-specific booster is “very fast and very good,” Bancel said, with detailed data likely to be released next month or April; it will be available this fall.
other reports
Australian miner Liontown signs 5-year lithium supply deal with Tesla
SEC Reportedly Investigating Trading Affiliates of Binance’s U.S. Branch
Mainland CPI, PPI fell in January and were lower than expected
Hong Kong stocks ADR up 285 points, night futures 298 points higher than water
Wynn Macau’s fourth-quarter loss widens by $208 million
Kirin sells stake in China beverage joint venture to mainland fund for 7.75 billion
Dow rises 422 points as Ukrainian situation eases
:quality(80)/cdn-kiosk-api.telegraaf.nl/ce5731ba-c172-11ef-932c-a6e8b863817e.jpg "Drones Spotted Near Secure Prison in Vught, Police Investigating")
